BioCentury | Sep 22, 2017
Company News

Management tracks: Unity, Shield, Tusk

...Klein. Goeltz was CFO at CytomX Therapeutics Inc. (NASDAQ:CTMX), Rich was SVP of operations at Kythera Biopharmaceuticals Inc....
BioCentury | Oct 31, 2016
Tools & Techniques

Slaying senescent cells

...management team,” Leonard noted. Arch, Partner Funds Management and Fidelity previously invested in dermatology company Kythera Biopharmaceuticals Inc....
...president and CEO. Prior to joining Venrock, partner Camille Samuels led Versant Venture’s investment in Kythera...
BioCentury | Sep 6, 2016
Company News

Management tracks

...company Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) named Elisabeth Sandoval chief commercial officer. She was CCO at Kythera Biopharmaceuticals Inc....
BioCentury | Apr 30, 2016
Financial News

Former Kythera team raises $34M for Sienna

...in a series A round. The start-up's management team includes former executives from aesthetics company Kythera Biopharmaceuticals Inc....
...Chairman Keith Leonard was Kythera's co-founder, president and CEO. Arch, Altitude and Partner were all Kythera...
BioCentury | Nov 5, 2015
Company News

Allergan strikes dry eye deal with Mimetogen

...was Botox, with $604.5 million in revenues in 3Q15. The company completed its acquisition of Kythera BioPharmaceuticals Inc....
BioCentury | Oct 26, 2015
Company News

Kythera, Allergan deal

...completed its acquisition of Kythera for about $2.1 billion in cash (see BioCentury, June 22). Kythera Biopharmaceuticals Inc....
BioCentury | Jul 13, 2015
Company News

Kythera sales and marketing update

...U.S. to reduce submental (under chin) fat. The drug is a synthetic sodium deoxycholate . Kythera Biopharmaceuticals Inc....
BioCentury | Jul 13, 2015
Finance

Mid-cap hot streak

...first-line and previously treated patients with advanced unresectable or metastatic melanoma, regardless of BRAF status Kythera...
BioCentury | Jul 9, 2015
Company News

Management tracks

...Brickell Biotech Inc. (Miami, Fla.) named Patricia Walker president and CSO. Walker was CMO at Kythera Biopharmaceuticals Inc....
BioCentury | Jun 22, 2015
Company News

Kythera, Allergan deal

...Allergan will acquire Kythera for about $2.1 billion in a cash and stock deal. Kythera shareholders...
...share in Allergan common shares. The $75 per share total is a 24% premium to Kythera’s...
...of $60.72 on June 16, the day before the deal was announced. Allergan will gain Kythera’s...
Items per page:
1 - 10 of 103
BioCentury | Sep 22, 2017
Company News

Management tracks: Unity, Shield, Tusk

...Klein. Goeltz was CFO at CytomX Therapeutics Inc. (NASDAQ:CTMX), Rich was SVP of operations at Kythera Biopharmaceuticals Inc....
BioCentury | Oct 31, 2016
Tools & Techniques

Slaying senescent cells

...management team,” Leonard noted. Arch, Partner Funds Management and Fidelity previously invested in dermatology company Kythera Biopharmaceuticals Inc....
...president and CEO. Prior to joining Venrock, partner Camille Samuels led Versant Venture’s investment in Kythera...
BioCentury | Sep 6, 2016
Company News

Management tracks

...company Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) named Elisabeth Sandoval chief commercial officer. She was CCO at Kythera Biopharmaceuticals Inc....
BioCentury | Apr 30, 2016
Financial News

Former Kythera team raises $34M for Sienna

...in a series A round. The start-up's management team includes former executives from aesthetics company Kythera Biopharmaceuticals Inc....
...Chairman Keith Leonard was Kythera's co-founder, president and CEO. Arch, Altitude and Partner were all Kythera...
BioCentury | Nov 5, 2015
Company News

Allergan strikes dry eye deal with Mimetogen

...was Botox, with $604.5 million in revenues in 3Q15. The company completed its acquisition of Kythera BioPharmaceuticals Inc....
BioCentury | Oct 26, 2015
Company News

Kythera, Allergan deal

...completed its acquisition of Kythera for about $2.1 billion in cash (see BioCentury, June 22). Kythera Biopharmaceuticals Inc....
BioCentury | Jul 13, 2015
Company News

Kythera sales and marketing update

...U.S. to reduce submental (under chin) fat. The drug is a synthetic sodium deoxycholate . Kythera Biopharmaceuticals Inc....
BioCentury | Jul 13, 2015
Finance

Mid-cap hot streak

...first-line and previously treated patients with advanced unresectable or metastatic melanoma, regardless of BRAF status Kythera...
BioCentury | Jul 9, 2015
Company News

Management tracks

...Brickell Biotech Inc. (Miami, Fla.) named Patricia Walker president and CSO. Walker was CMO at Kythera Biopharmaceuticals Inc....
BioCentury | Jun 22, 2015
Company News

Kythera, Allergan deal

...Allergan will acquire Kythera for about $2.1 billion in a cash and stock deal. Kythera shareholders...
...share in Allergan common shares. The $75 per share total is a 24% premium to Kythera’s...
...of $60.72 on June 16, the day before the deal was announced. Allergan will gain Kythera’s...
Items per page:
1 - 10 of 103